Company intelligence / Profile preview

Friesland Bank Investments

Leeuwarden, Friesland, Netherlands

Ownership: Private
Development stage: Other

Overview

Friesland Bank Investments was the private equity and venture capital arm of the Dutch-based Friesland Bank, which was acquired by Rabobank in 2012. The firm specialized in mid-market investments within the Netherlands, focusing on sectors such as healthcare, food and agriculture, and industrial services. Its healthcare portfolio included notable companies like the dental laboratory group Excent Tandtechniek and the ophthalmic surgery specialist Dutch Ophthalmic Research Center (DORC). Following the Rabobank acquisition, the division was merged with Rabo Capital to form Nordian Capital Partners, continuing its legacy of supporting Dutch enterprises through growth capital and buyouts.

Industry: Investors

Beyond the preview

Go deeper on Friesland Bank Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Friesland Bank Investments.

Explore the full profile